Biotech News & Trading Forum: Community User: Weedmaster

https://elemental.medium.com/a-supercomputer-analyzed-covid-19-and-an-interesting-new-theory-has-emerged-31cb8eba9d63 Interessanter Artikel über CV19

Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates https://finance.yahoo.com/amphtml/news/attention-biotech-investors-mark-calendar-220507051.html

Eton, 2 pdufa Termine diesen Monat

Our Take On Eton Pharmaceuticals https://seekingalpha.com/article/4371985

Weiß nicht ganz obs hier so toll reinpasst, aber ich sags trotzdem mal RA Medical hat morgen ne Präsentation, die lungern grade nahe dem Jahrestief herum, MC 21 mio, cash 41 mio Soll aber anscheinend im oktober ein vote zwecks RS kommen Bis dahin allerdings ein potentieller Turnaround kandidat http://stocktwits.com/Stocks_N_Scotch/message/239790299

Eiger mit pdufa im November, 👍

https://finance.yahoo.com/news/eiger-announces-peginterferon-lambda-lonafarnib-120000685.html

https://www.otcdynamics.com/vbiv-vbi-vaccines-presents-phase-3-sci-b-vac-data-at-easl-2020/

https://www.businesswire.com/news/home/20200830005006/en/FSD-Pharma-Announces-Phase-2-Clinical-Trial

Aimmune wird von nestle gekauft

https://www.biopharmcatalyst.com/news/2020/phase-3-biotech-stock-catalysts-to-watch-in-september-biotech-week-in-review

Marinus kommt mal auf die Watchlist. Danke Schorsch 👍.

https://finance.yahoo.com/news/billionaire-israel-englander-goes-big-193043507.html?theme=2&_v=1&color=1&hl=en&sp=1&guccounter=1

Bei Redhill könnte auch was gehen die nächsten Wochen A pre-scheduled independent Safety Monitoring Committee (SMC) has recommended that the U.S. Phase 2 COVID-19 study with opaganib continue with no changes; the study is more than 50% enrolled and enrollment is planned to be completed in the coming weeks -- The global Phase 2/3 COVID-19 study with opaganib, being conducted in parallel to the U.S. Phase 2 study, received approval in Italy; this study has also been approved in the UK, Russia and Mexico, and is under review in additional countries -- The first patients have been enrolled in the global Phase 2/3 study with opaganib, which is set to enroll up to 270 patients hospitalized with severe COVID-19 pneumonia across up to 40 clinical sites -- Potential submission of global emergency use applications as early as Q4/2020 https://www.benzinga.com/pressreleases/20/08/g17265222/redhill-biopharma-announces-positive-recommendation-from-independent-committee-to-continue-u-s-pha

CANF Piclidenoson Phase III rheumatoid arthritis and psoriasis interim data expected Q4 2020 Achieved efficacy and safety endpoints in Phase II NASH trial IND filed with FDA for Phase II study of Piclidenoson in treatment of COVID-19 https://www.benzinga.com/pressreleases/20/08/b17265212/can-fite-reports-second-quarter-2020-financial-results-provides-clinical-update

Auf ST spekulieren einige mit einem Aufkauf der CF Pipeline von 7-11 USD/Share, was natürlich der Wahnsinn wäre. Vor allem, weil man dann trotzdem noch Shares vom neuen Unternehmen hat. Also ich bleibe auf jeden Fall mal drinnen.